미국의 호스피스 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 지역별, 진단별 및 부문별 예측(2026-2033년)

U.S. Hospice Market Summary

The U.S. hospice market size was estimated at USD 31.2 billion in 2025 and is projected to reach USD 45.3 billion by 2033, growing at a CAGR of 4.8% from 2026 to 2033. The growth of the market is attributed to the rising prevalence of chronic diseases among rapidly growing geriatric populations. In addition, increasing need for quality healthcare services at home along with growing Medicare reimbursement for hospice care is expected to further drive the market growth over the forecast period.

The section below outlines the key factors driving the growth of hospice care services, highlighting the rising geriatric population, increasing prevalence of chronic and life-limiting diseases, and growing demand for compassionate end-of-life care. It also examines the role of integrated palliative support, personalized care approaches, and continuous, home-based care models in strengthening hospice services as a preferred care pathway.

U.S. Hospice Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. hospice market report based on type, location, and diagnosis.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Routine Home Care
• Continuous Home Care
• Inpatient Respite Care
• General Inpatient Care
• Location Outlook (Revenue, USD Million, 2021 - 2033)
• Hospice Center
• Hospital
• Home Hospice Care
• Skilled Nursing Facility
• Diagnosis Outlook (Revenue, USD Million, 2021 - 2033)
• Dementia
• Circulatory/Heart
• Cancer
• Respiratory
• Stroke
• Chronic Kidney Disease
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Type Segment
  • 1.2.2. Location Segment
  • 1.2.3. Diagnosis Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Hospice Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increased awareness of end-of-life care
    • 3.2.1.2. Rising preference for home-based care
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Growing prevalence of chronic conditions
    • 3.2.1.5. Increasing number of hospice centers
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Underutilization of hospice services among population
    • 3.2.2.2. Shortage of workforce
  • 3.2.3. Industry challenges analysis
    • 3.2.3.1. Correct documentation
    • 3.2.3.2. Misconceptions & late referrals
  • 3.2.4. Industry opportunity analysis
    • 3.2.4.1. Initiatives by hospice care centers
    • 3.2.4.2. Adoption of new technologies
• 3.3. Regulatory Framework & Reimbursement Scenario
• 3.4. State-wise Performance Metrics in Hospice Care Delivery in the U.S.
• 3.5. U.S. Hospice Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
    • 3.5.2.4. Environmental Landscape
    • 3.5.2.5. Legal Landscape
    • 3.5.2.6. Social Landscape

Chapter 4. U.S. Hospice Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Hospice Market Type Movement Analysis
• 4.3. U.S. Hospice Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Routine Home Care
  • 4.4.1. Routine home care market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Continuous Home Care
  • 4.5.1. Continuous home care market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Inpatient Respite Care
  • 4.6.1. Inpatient respite care market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. General Inpatient Care
  • 4.7.1. General inpatient care market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Hospice Market: Location Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Hospice Market Location Movement Analysis
• 5.3. U.S. Hospice Market Size & Trend Analysis, by Location, 2021 to 2033 (USD Million)
• 5.4. Hospice Center
  • 5.4.1. Hospice center market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Hospital
  • 5.5.1. Hospital market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Home Hospice Care
  • 5.6.1. Home hospital care market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. Skilled Nursing Facility
  • 5.7.1. Skilled nursing facility market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Hospice Market: Diagnosis Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Hospice Market Diagnosis Movement Analysis
• 6.3. U.S. Hospice Market Size & Trend Analysis, by Diagnosis, 2021 to 2033 (USD Million)
• 6.4. Dementia
  • 6.4.1. Dementia market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Circulatory/Heart
  • 6.5.1. Circulatory/Heart market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Cancer
  • 6.6.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Respiratory
  • 6.7.1. Respiratory market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Stroke
  • 6.8.1. Stoke market estimates and forecasts 2021 to 2033 (USD Million)
• 6.9. Chronic Kidney Disease
  • 6.9.1. Chronic kidney disease Market estimates and forecasts 2021 to 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2025
• 7.4. Company Profiles/Listing
  • 7.4.1. Chemed Corporation (VITAS Healthcare)
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. LHC Group, Inc. (UnitedHealth Group)
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Amedisys
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Gentiva
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Brookdale Senior Living, Inc
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Crossroads Hospice (Agape Care Group)
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Seasons Hospice
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Oklahoma Palliative & Hospice Care
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Compassus
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Chapters Health System
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives